GemVax&KAELLtd Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Sang-Jae Kim
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | no data |
Participación del CEO | 3.0% |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | sin datos |
Actualizaciones recientes de la dirección
Recent updates
Some Confidence Is Lacking In GemVax&KAEL Co.,Ltd. (KOSDAQ:082270) As Shares Slide 28%
Nov 04GemVax&KAEL Co.,Ltd.'s (KOSDAQ:082270) 30% Share Price Surge Not Quite Adding Up
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
Jul 05GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem
Apr 03Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?
Feb 17Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%
Dec 26CEO
Sang-Jae Kim (58 yo)
no data
Permanencia
Mr. Sang-Jae Kim serves as Chief Executive Officer at GemVax&KAEL Co.,Ltd. He serves as Co-Chief Executive Officer of BIOVILL Co.,Ltd. (formerly known as KSCB Co.,Ltd.) Mr. Kim serves as the Chief Executiv...